Phase 1 updated exploration and first expansion data for DLL3-targeted t-cell engager tarlatamab in small cell lung cancer
Borghaei, H. Paz-Ares, L. Johnson, M. Champiat, S. Owonikoko, T. Lai, V. Boyer, M. Hummel, H. D. Govindan, R. Steeghs, N.
Borghaei, H.
Paz-Ares, L.
Johnson, M.
Champiat, S.
Owonikoko, T.
Lai, V.
Boyer, M.
Hummel, H. D.
Govindan, R.
Steeghs, N.
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Borghaei H, Paz-Ares L, Johnson M, Champiat S, Owonikoko T, Lai V, et al. Phase 1 Updated Exploration and First Expansion Data for DLL3-targeted T-cell Engager Tarlatamab in Small Cell Lung Cancer. Journal of Thoracic Oncology. 2022 Sep;17(9):S33-S. PubMed PMID: WOS:000858678100053.